Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

Tetrahydrocannabinol induces a range of neurotic symptoms in healthy people

Staff Writer
Staff Writer 5 years ago
Updated 2020/03/22 at 11:18 PM
Share
SHARE

Among healthy people, the consumption of a psychoactive component known as tetrahydrocannabinol could induce psychotic and affective symptoms, such as depression and anxiety, according to a new study.

The results, released online in The Lancet Psychiatry, were reached through the systematic review and meta-analysis of studies published up to mid-2019. Databases like PsycINFO, MEDLINE, and Embase, were scoured for studies on tetrahydrocannabinol and subsequent psychiatric symptoms.

In those studies, researchers focused on the presence of psychiatric symptoms, using certain scales to look for criteria and the administration of tetrahydrocannabinol, cannabidiol and placebo in healthy adults. The Brief Psychiatric Rating Scale and the Positive and Negative Syndrome Scale were used to measure any exhibition of psychotic-like or affective symptoms.

“We did a random-effects meta-analysis to assess the main outcomes of the effect sizes for total, positive, and negative PANSS and BPRS scores measured in healthy participants following tetrahydrocannabinol (THC) administration versus placebo,” the findings state. “Because the number of studies to do a meta-analysis on CBD’s moderating effects was insufficient, this outcome was only systematically reviewed.”

From scouring all available databases, 15 studies of tetrahydrocannabinol were identified as eligible and analyzed for potential psychological effects compared to a placebo.

In the findings, tetrahydrocannabinol drastically surged the severity of both psychotic-like and affective symptoms. “A single THC administration induces psychotic, negative, and other psychiatric symptoms with large effect sizes. There is no consistent evidence that CBD induces symptoms or moderates the effects of THC,” the study’s co-authors found.

For individuals consuming substances containing tetrahydrocannabinol, especially through intravenous administration or inhalation, the component is more likely to induce psychotic-like symptoms rather than depressive or anxiety traits, the findings showed.

“This result contrasts with findings from several primary studies that report dose–response relationships and evidence of a blunted psychotomimetic effect among regular cannabis users.”

Researchers also concluded the tetrahydrocannabinol-induced psychotic-like effects was less prevalent among individuals with higher tobacco use, a contradictory revelation to prior studies indicating a casual relationship between tobacco smoking and psychotic illness.

“The association between lower induction of psychotic symptoms by THC and higher tobacco use might also relate to the upregulation of UDP-glucuronosyltransferase by nicotine, which in turn is implicated in the metabolism of THC,” the study determined.

“In conclusion, these findings demonstrate that the acute administration of THC induces positive, negative, and general psychiatric symptoms with large effect sizes,” researchers attested. “These findings highlight the acute risks of cannabis use, which are highly relevant as medical, societal, and political interest in cannabinoids continues to grow.”

Photo: Getty Images

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

Study shows the risk of eating disorders may be lower among vegans

TAGGED: cannabidiol, tetrahydrocannabinol, psychosis, substance use
Staff Writer March 22, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Psychostimulants increase attention on the benefits of a task and not perceived costs
Next Article Many Americans think the media is covering COVID-19 pandemic well, but exaggerating the risks, survey finds

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
Clinical

Researchers investigate how endocannabinoids regulate the brain’s stress response

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?